Screening lead compounds for QT interval prolongation
- 1 January 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (2) , 78-84
- https://doi.org/10.1016/s1359-6446(00)01602-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmiasExpert Opinion on Pharmacotherapy, 2000
- QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.European Journal of Clinical Pharmacology, 2000
- MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac ArrhythmiaPublished by Elsevier ,1999
- Dysfunction of Delayed Rectifier Potassium Channels in an Inherited Cardiac ArrhythmiaAnnals of the New York Academy of Sciences, 1999
- Preclinical In Vitro Cardiac ElectrophysiologyDrug Safety, 1999
- Molecular genetics of long-QT syndromeCurrent Opinion in Pediatrics, 1998
- Acquired QT ProlongationCardiology in Review, 1998
- Ion Channels — Basic Science and Clinical DiseaseNew England Journal of Medicine, 1997
- THE CARDIAC ION CHANNELS: Relevance to Management of ArrhythmiasAnnual Review of Medicine, 1996
- HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel FamilyScience, 1995